Cryoport provides leading edge cryogenic logistics solutions to the life sciences industry through the combination of purpose built proprietary packaging, advanced information technology and highly skilled logistics expertise which manages the entire cold chain logistics process. Cryoport Express liquid nitrogen dry vapor shippers are validated to maintain a constant C temperature for a plus day dynamic shipment duration, and its Cryoportal Logistics Management Platform assists in managing the entire logistics process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a green and environmentally friendly solution. Cryoport service options include recording the chain of condition and chain of custody for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.
Quote | CryoPort Inc. (NASDAQ:CYRX)
Last: | $12.65 |
---|---|
Change Percent: | -0.15% |
Open: | $13.68 |
Close: | $12.65 |
High: | $13.68 |
Low: | $12.62 |
Volume: | 343,142 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | CryoPort Inc. (NASDAQ:CYRX)
2024-05-07 21:50:26 ET Cryoport, Inc. (CYRX) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Todd Fromer – Investor Relations-KCSA Strategic Communications Jerrell Shelton – Chief Executive Officer Mark Sawicki – ...
2024-05-07 16:21:45 ET More on CryoPort Cryoport Tanks On Chilling Results And Bad Decisions Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript B. Riley cuts Cryoport to neutral, cites top-line growth Seeking Alpha’s Quant Rating on CryoPort ...
Message Board Posts | CryoPort Inc. (NASDAQ:CYRX)
Subject | By | Source | When |
---|---|---|---|
Boston IVF Agreement: Reproductive Material Shipments Across the U.S. | H2R | investorshub | 04/26/2023 5:20:40 PM |
Bjorn: Thanks for the link | Bjorn | investorshangout | 03/13/2023 3:36:02 PM |
whytestocks: $CYRX News Article - Cryoport Confirms No Financial Exposure to Silicon Valley Bank | whytestocks | investorshangout | 03/13/2023 3:30:57 PM |
whytestocks: $CYRX News Article - Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer P | whytestocks | investorshangout | 03/08/2023 7:15:48 PM |
That's a big if however if that | Jim l | investorshub | 02/26/2023 6:47:12 AM |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities ...
Cryoport Reports First Quarter 2024 Financial Results PR Newswire Q1 2024 revenue of $54.6 million 9% year-over-year increase in Commercial Cell & Gene Therapy revenue 9% year-over-year increase in BioStorage/BioServices revenue A total of 675...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...